Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines.

× No keyword cloud information.

7 in total

1. Value regimes and pricing in the pharmaceutical industry: financial capital inflation (hepatitis C) versus innovation and production capital savings for malaria medicines.

Authors: Maurice Cassier
Journal: Biosocieties Date: 2021-01-13

2. Access considerations for a COVID-19 vaccine for South Africa.

Authors: Varsha Bangalee; Fatima Suleman
Journal: S Afr Fam Pract (2004) Date: 2020-10-29

3. Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan.

Authors: Hideki Maeda; Ayano Okabe; Kenichi Sakakura; Daniel Bin Ng; Manabu Akazawa
Journal: BMC Health Serv Res Date: 2021-12-11 Impact factor: 2.655

4. Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections-Overview of Policies Applied in 17 European Countries.

Authors: Sabine Vogler; Friederike Windisch
Journal: Antibiotics (Basel) Date: 2022-07-22

5. Indication-wide drug pricing: Insights from the pharma market.

Authors: Florian Siegmeier; Melanie Büssgen
Journal: J Pharm Policy Pract Date: 2022-08-29

6. Value drivers of development stage biopharma companies.

Authors: Daniel Tobias Michaeli; Hasan Basri Yagmur; Timur Achmadeev; Thomas Michaeli
Journal: Eur J Health Econ Date: 2022-01-17

7. Radical Approaches During Unusual Circumstances: Intellectual Property Regulation and the COVID-19 Dilemma.

Authors: Mohammed El Said
Journal: Development (Rome) Date: 2020-11-06

7 in total